Nuzenio

Mass Cytometry

Mass Cytometry news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Timeline

Tue, 28 Jul 2026 12:32:40 GMTStandard BioTools Sells Mass Cytometry Business and Secures $30 Million Illumina Buyout Ahead of Treeline Merger - citybiz.co
Tue, 28 Jul 2026 12:25:42 GMTStandard BioTools (NASDAQ: LAB) nets $30M Illumina buyout, sells mass cytometry arm - Stock Titan
Tue, 28 Jul 2026 07:00:00 GMTStandard BioTools (LAB) plans sale of Mass Cytometry business alongside Treeline deal - Stock Titan
Tue, 28 Jul 2026 07:00:00 GMTStandard BioTools Announces Sale of Mass Cytometry Business and Illumina’s Buyout of Contingent Payments to Advance Merger with Treeline Biosciences - Sahm
Tue, 28 Jul 2026 07:00:00 GMTStandard BioTools sells Mass Cytometry business and secures $30M from Illumina earnout buyout - Pluang
Mon, 27 Jul 2026 07:00:00 GMTMultiplex BioTech Private Limited agreed to acquire Mass Cytometry Business of Standard BioTools Inc. (NasdaqGS : LAB) for $10 million. - marketscreener.com

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Mass Cytometry.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.